Phase 1 Study of ABT‐751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer
Author:
Affiliation:
1. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore MD USA
2. University of Colorado Cancer Center Denver CO USA
3. Centro Integral Oncologico Clara Campal Madrid Spain
Funder
Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.681
Reference33 articles.
1. Cancer statistics, 2010;Jemal A;CA,2010
2. Microtubule Dynamics: Mechanism, Regulation, and Function
3. Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors
4. Tumor selective antivascular effects of the novel antimitotic compound ABT-751: an in vivo rat regional hemodynamic study
5. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin;Yoshimatsu K;Cancer Res,1997
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An update on the development on tubulin inhibitors for the treatment of solid tumors;Expert Opinion on Therapeutic Targets;2024-03-03
2. Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo;ACS Pharmacology & Translational Science;2023-03-22
3. Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities;European Journal of Medicinal Chemistry;2022-08
4. Discovery of 4-methoxy-N-(1-naphthyl)benzenesulfonamide derivatives as small molecule dual-target inhibitors of tubulin and signal transducer and activator of transcription 3 (STAT3) based on ABT-751;Bioorganic Chemistry;2022-08
5. IMB5476, a novel microtubule inhibitor, induces mitotic catastrophe and overcomes multidrug resistance in tumors;European Journal of Pharmacology;2022-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3